ecabapide has been researched along with Anemia, Hemolytic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kakihata, K; Nomura, M; Ohno, H; Takayama, S; Tojo, H | 1 |
Nomura, M; Ohno, H; Watanabe, K | 1 |
Akiyama, Y; Genda, Y; Jindo, T; Kakihata, K; Ohno, H | 1 |
3 other study(ies) available for ecabapide and Anemia, Hemolytic
Article | Year |
---|---|
Heinz body hemolytic anemia induced by DQ-2511, a new anti-ulcer drug, in dogs.
Topics: Administration, Oral; Anemia, Hemolytic; Animals; Anti-Ulcer Agents; Benzamides; Dogs; Dose-Response Relationship, Drug; Erythrocyte Count; Erythrocytes; Glutathione; Heinz Bodies; Hematocrit; Hemoglobins; Male; Phenylhydrazines | 1993 |
A possible mechanism of heinz body hemolytic anemia induced by DQ-2511, a new gastroprokinetic drug, in dogs.
Topics: Anemia, Hemolytic; Animals; Anti-Ulcer Agents; Benzamides; Dogs; Drug Administration Schedule; Erythrocytes; Female; Male; Phenylhydrazines; Rats; Rats, Sprague-Dawley | 1996 |
Thirteen-week repeated oral dose toxicity study of ecabapide, a gastroprokinetic drug, in dogs and rats.
Topics: Administration, Oral; Anemia, Hemolytic; Animals; Anti-Ulcer Agents; Benzamides; Blood Proteins; Body Weight; Dogs; Dose-Response Relationship, Drug; Erythropoiesis; Female; Kidney; Liver; Male; No-Observed-Adverse-Effect Level; Rats; Rats, Sprague-Dawley; Salivation; Spleen; Time Factors; Vomiting | 1998 |